Pavion Blue Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Pavion Blue Capital's AMGN Position: Q1 2026 in Review
Pavion Blue Capital reduced its Amgen (AMGN) stake by 0.87% in Q1 2026, selling an estimated $8.91K and leaving 2,846 shares worth $1M. The position accounts for 0.43% of the portfolio, ranked #47.
Pavion Blue Capital first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Pavion Blue Capital held 2,846 shares of Amgen worth $1M as of Q1 2026.
- Pavion Blue Capital sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
- Amgen made up 0.43% of Pavion Blue Capital's portfolio in Q1 2026, its #47 holding.
- Pavion Blue Capital first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.